Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Human Vaccines & Immunotherapeutics

• Publication date

  2017-02-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/21645515.2016.1246636PMID 28277090PMCID PMC5360136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Key roles of adjuvants in modern vaccines

  2013cited by this paper
• Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.

  2012cited by this paper
• Short communication: immunogenicity of an inactivated influenza vaccine and postvaccination influenza surveillance in HIV-infected and noninfected children and adolescents.

  2011cited by this paper
• Immunogenicity Is Not Improved by Increased Antigen Dose or Booster Dosing of Seasonal Influenza Vaccine in a Randomized Trial of HIV Infected Adults

  2011cited by this paper
• Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial.

  2011cited by this paper
• Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients.

  2011cited by this paper
• Regulation of Antinucleoprotein IgG by Systemic Vaccination and Its Effect on Influenza Virus Clearance

  2011cited by this paper
• An Adjuvant for the Induction of Potent, Protective Humoral Responses to an H5N1 Influenza Virus Vaccine with Antigen-Sparing Effect in Mice

  2010cited by this paper
• Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

  2010cited by this paper
• Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals

  2010cited by this paper
• Proinflammatory Adjuvants Enhance the Cognate Helper Activity of Aged CD4 T Cells1

  2009cited by this paper
• Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques

  2009cited by this paper
• CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years.

  2008cited by this paper
• Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.

  2008cited by this paper
• Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection.

  2007influential reference
• Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination.

  2007cited by this paper
• High interleukin‐10 production is associated with low antibody response to influenza vaccination in the elderly

  2006cited by this paper
• CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults

  2005cited by this paper
• Efficacy and Immunologic Responses to Influenza Vaccine in HIV-1-Infected Patients

  2005cited by this paper
• Age-Related Impaired Type 1 T Cell Responses to Influenza: Reduced Activation Ex Vivo, Decreased Expansion in CTL Culture In Vitro, and Blunted Response to Influenza Vaccination In Vivo in the Elderly1

  2004cited by this paper
• Toll-Like Receptor Ligands Directly Promote Activated CD4+ T Cell Survival

  2004cited by this paper
• Inflammatory Cytokines Overcome Age-Related Defects in CD4 T Cell Responses In Vivo1

  2004cited by this paper
• Interleukin-12 and the regulation of innate resistance and adaptive immunity

  2003cited by this paper
• Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

  2002cited by this paper
• Highly Immunogenic and Totally Synthetic Lipopeptides as Self-Adjuvanting Immunocontraceptive Vaccines1

  2002cited by this paper
• Intranasal Immunization with CpG Oligodeoxynucleotides as an Adjuvant Dramatically Increases IgA and Protection Against Herpes Simplex Virus-2 in the Genital Tract1

  2001cited by this paper
• An overview of real-time quantitative PCR: applications to quantify cytokine gene expression.

  2001cited by this paper
• Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.

  2001cited by this paper
• Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.

  2000cited by this paper
• Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study.

  2000cited by this paper
• Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.

  2000cited by this paper
• CpG DNA is an effective oral adjuvant to protein antigens in mice.

  2000cited by this paper
• T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock

  2000cited by this paper
• Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response.

  1999cited by this paper
• Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells.

  1999cited by this paper
• Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein.

  1999cited by this paper
• Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells.

  1997cited by this paper
• Antibody response to influenza, tetanus and pneumococcal vaccines in HIV‐seropositive individuals in relation to the number of CD4+ lymphocytes

  1994cited by this paper
• The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine.

  1989cited by this paper
• Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses

  1981cited by this paper
• Adjuvant Effects of Low Doses of a Nuclease-Resistant Derivative of Polyinosinic Acid · Polycytidylic Acid on Antibody Responses of Monkeys to Inactivated Venezuelan Equine Encephalomyelitis Virus Vaccine

  1979cited by this paper
• Association of serum anti-neuraminidase antibody with resistance to influenza in man.

  1972cited by this paper
• Protective Effects of Specific Immunity to Viral Neuraminidase on Influenza Virus Infection of Mice

  1968cited by this paper

• Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV

  2022cites this paper
• Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components

  2021cites this paper
• Travel vaccination recommendations and infection risk in HIV-positive travellers.

  2019cites this paper
• Adverse events after vaccination among HIV-positive persons, 1990–2016

  2018cites this paper
• Impfen bei Immundefizienz

  2018influential citation
• Impfen bei Immundefizienz

  2017cites this paper